Drug delivery across the skin

Expert Opinion on Biological Therapy

Volumn 2, Issue 7, 2002, Pages 723-733

  Touitou, Elka ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Drug delivery; Electrically assisted delivery; Ethosomes; Microinvasive delivery; Microneedle; Permeation enhancement; Topical; Transdermal; Transfersomes

Indexed keywords

1,3 DIOXOLANE DERIVATIVE; LAUROCAPRAM; LIPOSOME; PROSTAGLANDIN E1;

DRUG DELIVERY SYSTEM; ECHOGRAPHY; ELECTRIC CONDUCTIVITY; ELECTROPORATION; IONTOPHORESIS; NEEDLE; REVIEW; SKIN PERMEABILITY; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, TOPICAL; ANIMALS; DRUG CARRIERS; DRUG THERAPY; ELECTROPORATION; EXCIPIENTS; HUMANS; IONTOPHORESIS; MICROSPHERES; NEEDLES; SKIN ABSORPTION; ULTRASONICS;

EID: 0036793195     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2.7.723     Document Type: Review

References (70)

1. Smith EW, Maibach HI (Eds): Percutaneous penetration enhancers. CRS Press, NY, USA (1995). This book presents theories and mechanisms of action of chemical and physical enhancement methods.
2. Goodman M, Barry BW: Action of penetration enhancers on human stratum corneum as assessed by differential scanning calorimetry. In: Percutaneous Absorption: Mechanisms-Methodology-Drug Delivery. Bronaugh RL, Maibach HI (Eds) Marcel Dekker, Inc., NY, USA (1989):567-594. Excellent chapter on mechanisms of chemical penetration enhancers' action by examining the thermal behaviour of human stratum corneum.
3. Touitou E: Transdermal delivery of anxiolytics: in vitro skin permeation of midazolam maleate and diazepam. Int. J. Pharm. (1986) 33:37-43.
4. Hadgraft J: Modulation of the barrier function of the skin. Skin Pharmacol. Appl. Skin Physiol. (2001) 14(Suppl. 1):72-81.
5. Pilgram GS, Engelsma-Van Pelt AM, Koerten HK, Bouwstra JA: The effect of two azones on the lateral lipid organization of human stratum corneum and its permeability. Pharm. Res. (2000) 17:796-802. Good paper on effect of azones on lipid organisation of stratum corneum.
6. Philips CA, Michinak BB: Transdermal delivery of drugs with differing lipophilicities using azone analogs as dermal penetration enhancers. J Pharm. Sci. (1995) 84:1427-1433.
7. Investigational Drugs Database (2002).
8. Marty JP: Transdermal 7-day HRT. J. Menopause (2000) 2:17-18.
9. Ongpipattanakul B, Burnette RR, Potts RO, Francoeur M: Evidence that oleic acid exists in a separate phase within stratum corneum lipids. Pharm. Res. (1991) 8:350-354. Paper presenting one mode of action of oleic acid.
10. Touitou E, Godin B, Karl Y, Bujanover S, Becker Y: Oleic acid, a skin penetration enhancer, affects Langerhans cells and corneocytes. J. Control Release (2002) 80:1-7.
11. Winters SJ: Current status of testosterone replacement therapy in men. Arch. Fam. Med. (1999) 8:257-263.
12. Kalia YN, Merino V, Guy RH: Transdermal drug delivery. Clinical aspects. Dermatol. Clin. (1998) 16:289-299.
13. Berner B, Liu P: Alcohols in percutaneous penetration enhancers. In: Percutaneous Penetration Enhancers. Smith EW, Maibach HI (Eds) CRS Press, NY, USA (1995):45-60.
14. Touitou E, Fabin B: Altered skin permeation of a highly lipophilic molecule: tetrahydrocannabinol. Int. J. Pharm. (1988) 43:17-22.
15. Ghanem AH, Mahmoud H, Higuchi WI, Liu P, Good WR: The effects of ethanol on the transport of lipophilic and polar permeants across hairless mouse skin: methods/validation of a novel approach. J. Control. Release (1999) 59:149-161.
16. Magee PS: Some new approaches to understanding and facilitating transdermal drug delivery. In: Percutaneous Penetration Enhancers. Smith EW, Maibach HI (Eds) CRS Press, NY, USA (1995):471-480.
17. Touitou E, Chow DD, Lawter JR: Chiral β-blockers for transdermal delivery. Int. J. Pharm. (1994) 104:19-28.
18. Kaplun-Frischoff Y, Touitou E: Testosterone skin permeation enhancement by menthol through formation of eutectic with drug and interaction with skin lipids. J. Pharm. Sci. (1997) 86:1394-1399.
19. Stott PW, Williams AC, Barry BW: Transdermal delivery from eutectic systems: enhanced permeation of a model drug, ibuprofen. J. Control Release (1998) 50:297-308.
20. Kang L, Jun HW, Mccall JW: Physicochemical studies of lidocaine-menthol binary systems for enhanced membrane transport. Int. J. Pharm. (2000) 206:35-42.
21. Stott PW, Williams AC, Barry BW: Mechanistic study into the enhanced transdermal permeation of a model beta-blocker, propranolol, by fatty acids: a melting point depression effect. Int. J. Pharm. (2001) 219:161-176.
22. Juhlin L, Hagglund G, Evers H: Absorption of lidocaine and prilocaine after application of a eutectic mixture of local anesthetics (EMLA) on normal and diseased skin. Acta Derm. Venereol. (1989) 69:18-22.
23. Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M: Ethosomes -novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J. Control Release (2000) 65:403-418.
24. Cevc G, Schatzein A, Blume G: Transdermal drug carriers: basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides. J. Control. Release (1995) 36:3-16.
25. Foong WC, Harsanyi BB, Mezei M: Biodisposition and histological evaluation of topically applied retinoic acid in liposomal cream and gel dosage forms. In: Phospholipids. Haning I, Pepeu G (Eds) Plenum Press, New York, NY (1990):279-282.
26. Touitou E, Shaco-Ezra N, Dayan N, Jushynski M, Rafaeloff R, Azoury R: Diphylline liposomes for delivery to the skin. J. Pharm. Sci. (1992) 81:131-134.
27. Planas ME, Gonzalez P, Rodriguez L, Sanchez S, Cevc G: Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anesthetic liposomes. Anesth. Analg. (1992) 75:615-621.
28. Touitou E, Junginger HE, Weiner ND, Nagai T, Mezei M: Liposomes as carriers for topical and transdermal delivery. J. Pharm. Sci. (1994) 83:1189-1203.
29. Touitou E, Levi-Schaffer F, Dayan N, Alhaiquef, Riccieri F: Modulation of caffeine skin delivery by carrier design: liposomes versus permeation enhancers. Int. J. Pharm (1994) 103:131-136.
30. Lauer AC, Lieb LM, Ramachandran C, Flynn GL, Weiner ND: Transfollicular drug delivery. Pharm. Res. (1995) 12:179-186.
31. Arunothayanun P, Turton JA, Uchegbu IF, Florence AT: Preparation and in vitro/in vivo evaluation of luteinizing hormone releasing hormone (LHRH)-loaded polyhedral and spherical/tubular niosomes. J. Pharm. Sci. (1999) 88:34-38.
32. Schreier H, Bouwstra JA: Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J. Control. Release (1994) 30:1-15.
33. Cevc G: Transfersomes, liposomes and other lipid suspensions on the skin: permeation vesicle penetration and transdermal drug delivery. Crit. Rev. Ther. Drug Car. Sys. (1996) 13:257-388.
34. Cevc G, Blume G: New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim. Biophys. Acta. (2001) 1514:191-205.
35. Cevc G, Blume G: Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim. Biophys. Acta. (1992) 1104:226-235.
36. El Maghraby GM, Williams AC, Barry BW: Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int. J. Pharm. (2000) 196:63-74.
37. R&D Focus. IMSWorld Publications Ltd (13 March 2002). IDEA 1999.
38. Dayan N, Touitou E: Carrier for skin delivery of trihexyphenidyl hydrochloride: ethosomes versus liposomes. Biomaterials (2000) 21:1879-1885.
39. Touitou E, Godin B, Weiss C: Enhanced delivery of drugs into and across the skin by ethosomal carriers. Drug Dev. Res. (2000) 50:406-415.
40. Dkeidek I, Touitou E: Transdermal absorption of polypeptides. AAPS Pharm. Sci. (1999) 1:S202.
41. Horwitz E, Pisanty S, Czerninski R, Helser M, Eliav E, Touitou E: A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. (1999) 88:700-705.
42. Riviere JE, Heit MC: Electrically-assisted transdermal drug delivery. Pharm. Res. (1997) 14:687-697.
43. Banga AK, Bose S, Ghosh TK: Iontophoresis and electroporation: comparisons and contrasts. Int. J. Pharm (1999) 179:1-19.
44. Chien YW: Systemic delivery of peptide-based pharmaceuticals by transdermal periodic iontotherapeutic system. In: Dermal and Transdermal Drug Delivery: New Insights and Perspectives. Gurny R, Teubner A (Eds) Wissenschaftliche Verlags GmbH, Stuttgart, Germany (1993):129-152.
45. Miller LL, Kolaskie CJ, Smith GA, Rivier J: Transdermal iontophoresis of gonadotropin releasing hormone (LHRH) and two analogues. J. Pharm. Sci. (1990) 79:490-493.
46. Srinivasan V, Su M-H, Higuchi WI, Behl CR: Iontophoresis of polypeptides: effect of ethanol pretreatment of human skin. J. Pharm. Sci. 79:588-591.
47. Bhatia KS, Singh J: Mechanism of transport enhancement of LHRH through porcine epidermis by terpenes and iontophoresis: permeability and lipid extraction studies. Pharm. Res. (1998) 15:1857-1862.
48. Langkjaer L, Brange J, Grodsky GM, Guy RH: Iontophoresis of monomeric insulin analogues in vitro: effects of insulin charge and skin pretreatment. J. Control. Release(1998) 51:47-56.
49. Huang YY, Wu SM, Wang CY: Response surface method: a novel strategy to optimize iontophoretic transdermal delivery of thyrotropin-releasing hormone. Pharm. Res. (1996) 13:547-552.
50. Banga AK, Katakam M, Mitra R: Transdermal iontophoretic delivery and degradation of vasopressin across human cadaver skin. Int. J. Pharm. (1995) 116:211-216.
51. Santi P, Colombo P, Bettini R, Catellani PL, Minutello A, Volpato NM: Drug reservoir composition and transport of salmon calcitonin in transdermal iontophoresis. Pharm. Res. (1997) 14:63-66.
52. Guy RH, Delgado-Charro MB, Kalia YN: Iontophoretic transport across the skin. Skin Pharmacol. Appl. Skin Physiol. (2001) 14(Suppl. 1):35-40.
53. Guy RH: A sweeter life for diabetics? Nat. Med. (1995) 1:1132-1133.
54. Singh J, Gross M, Sage B, Davis HT, Maibach HI: Regional variations in skin barrier function and cutaneous irritation due to iontophoresis in human subjects. Food Chem. Toxicol. (2001) 39:1079-1086.
55. Banga AK, Prausnitz MR: Assessing the potential of skin electroporation for the delivery of protein-and gene-based drugs. Trends Biotech. (1998) 16:408-412.
56. Prausnitz MR, Edelman ER, Gimm JA, Langer R, Weaver JC: Transdermal delivery of heparin by skin electroporation. Biotechnology (1995) 13:1205-1209.
57. Zewert TE, Pliquett UF, Langer R, Weaver JC: Transdermal transport of DNA antisense oligonucleotides by electroporation. Biochem. Biophys. Res. Com. (1995) 212:286-292.
58. Bommannan DB, Tamada J, Leung L, Potts RO: Effect of electroporation on transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH) in vitro. Pharm. Res. (1994) 11:1809-1814.
59. Vanbever R, Prausnitz MR, Preat V: Macromolecules as novel transdermal enhancers for skin electroporation. Pharm. Res. (1997) 14:638-644.
60. Kost J: Ultrasound and transdermal transport for drug delivery and diagnostics Pharma Tech (2001):196-202.
61. Benson HAE, Mcelnay JC: Topical non-steroidal anti-inflammatory products as ultrasound couplants: Their potential in phonophoresis. Physiotherapy (1994) 80:74-76.
62. Byl NN: The use of ultraound as an enhancer for transcutaneous drug delivery: Phonophoresis. Physical Therapy (1995) 75:539-553.
63. Mitragotri S, Blankschtein D, Langer R: Ultrasound-mediated transdermal protein delivery. Science (1995) 269(5225):850-853.
64. Ueda H, Ogihara M, Sugibayashi K, Morimoto Y: Difference in the enhancing effects of ultrasound on the skin permeation of polar and non-polar drugs. Chem. Pharm. Bull. (Tokyo) (1996) 44:1973-1976.
65. Mitragotri S: Effect of therapeutic ultrasound on partition and diffusion coefficients in human stratum corneum. J. Control Release. (2001) 71:23-29.
66. Boucaud A, Montharu J, Machet L et al.: Clinical, histological and electron microscopy study of skin exposed to low-frequency ultrasound. Anat. Rec. (2001) 264:114-119.
67. Henry S, Mcallister DV, Allen MG, Prausnitz MR: Microfabricated microneedles: a novel approach to transdermal drug delivery. J. Pharm. Sci. (1998) 87:922-925. Describes the approach of microneedles in transdermal delivery.
68. Kaushik S, Hord AH, Denson DD, Mcallister DV, Smitra S, Allen MG et al.: Lack of pain associated with microfabricated microneedles. Anesth. Analg. (2001) 92:502-504.
69. Schaefer H, Redelmeier TE (Eds): Skin Barrier. Principles of Percutaneous Absorption. Karger, Basel, Switzerland (1996).
70. Kydonieus A, Wille J (Eds): Biochemical Modulation of Skin Reactions: Transdermals, Topicals, Cosmetics. CRS Press, Boca Raton, FL (2000).